| 规格 | 价格 | 库存 |
|---|---|---|
| 25µg | ¥ 1568 | 1 |
IHC-P - Quality tested
WB - Verified
Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining. For immunohistochemisty, a concentration range of 0.5 - 5.0 μg/mL is suggested. For western blotting, the suggested use of this reagent is 1.0 - 5.0 ?g/mL. It is recommended that the reagent be titrated for optimal performance for each application.
Monoclonal antibody against glial fibrillary acidic protein (GFAP) derived from the Bigner-Eng clone MAb2E1.
SMI 24 provides for general visualization of GFAP in astrocytes and Bergman glia, it detects a more selected group of astrocytomas than mixtures of SMI 23, 24 and 25. The significance of this selectivity has not yet been explored. Possibilities are different characteristics of individual tumors or cooperativity of antibodies.
Multiple protein fragments ranging from 38 to 48 kD have been reported in human CNS lysates resulting from caspase- and calpain-mediated cleavage of GFAP.
GFAP is expressed by numerous cell types of the central nervous system (CNS) including astrocytes, ependymal cells, and Bergmann glia cells (unipolar protoplasmic astrocyte). GFAP is expressed in cells lacking fibronectin.
1. Khakh BS, et al. 2015. Nat. Neurosci. 18(7): 942. [PubMed]
2.?Brenner M. 2014. Neurosci. Lett. 565, 7-13. [PubMed]
3.?Hol EM, et al. 2015. Curr. Opin. Cell. Biol. 32:121. [PubMed]